Race Oncology is pleased to announce that international cardiometabolic expert, Associate Professor Erin Howden has been appointed to Race’s Scientific Advisory Board. Dr. Howden brings a wealth of experience to Race, having published more than 100 scientific publications on numerous topics, including the serious adverse effects that chemotherapy has on the cardiovascular fitness of cancer patients.

• Associate Professor Erin Howden is a world-leading expert on the serious negative effects of chemotherapy on cardiorespiratory fitness and patient quality of life

• Head of the Cardiometabolic Health and Exercise Physiology Lab and co-lead of the Physical Activity Program at the Baker Heart and Diabetes Institute

• Appointment enhances Race’s cardioprotection-focused clinical program.